Search Results

Filter
  • 1-10 of  667 results for ""Isocitrate Dehydrogenase""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery.

  • Authors : Park YW; Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, Seoul, Korea.; Jang G

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology ; Glioblastoma*/Glioblastoma*/Glioblastoma*/diagnostic imaging ; Glioblastoma*/Glioblastoma*/Glioblastoma*/epidemiology

  • Source: Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1921-1932.Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma.

  • Authors : Xu S; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, and Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, People's Republic of China.; Cao L

Subjects: Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/genetics ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/genetics ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology

  • Source: The oncologist [Oncologist] 2024 Aug 05; Vol. 29 (8), pp. e1061-e1072.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas.

  • Authors : Kinslow CJ; Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian, New York, New York, USA.; Department of Radiation Oncology, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian, New York, New York, USA.

Subjects: Antineoplastic Agents, Alkylating*/Antineoplastic Agents, Alkylating*/Antineoplastic Agents, Alkylating*/therapeutic use ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics

  • Source: Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1839-1849.Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

Subjects: Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/genetics ; Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/antagonists & inhibitors ; Glioma*/Glioma*/Glioma*/genetics

  • Source: Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1805-1822.Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Raman-based machine-learning platform reveals unique metabolic differences between IDHmut and IDHwt glioma.

  • Authors : Lita A; National Cancer Institute, National Institutes of Health, Neuro-Oncology Branch, Bethesda, Maryland, USA.; Sjöberg J

Subjects: Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/genetics ; Glioma*/Glioma*/Glioma*/genetics ; Glioma*/Glioma*/Glioma*/metabolism

  • Source: Neuro-oncology [Neuro Oncol] 2024 Nov 04; Vol. 26 (11), pp. 1994-2009.Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

FH-mutant glioma displaying the epigenetic signature of IDH-mutant astrocytomas.

  • Authors : Zschernack V; Department of Neuropathology, DGNN Brain Tumor Reference Center, University Hospital Bonn, Bonn, Germany.; Thomas C

Subjects: Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/genetics ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/pathology

  • Source: Journal of neuropathology and experimental neurology [J Neuropathol Exp Neurol] 2024 Oct 01; Vol. 83 (10), pp. 887-889.Publisher: Oxford University Press Country of Publication: England NLM ID: 2985192R Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma.

  • Authors : Massaad E; Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.; Smith WJ

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/surgery ; Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology

  • Source: Neuro-oncology [Neuro Oncol] 2024 Sep 05; Vol. 26 (9), pp. 1660-1669.Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Generative AI in glioma: Ensuring diversity in training image phenotypes to improve diagnostic performance for IDH mutation prediction.

  • Authors : Moon HH; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.; Jeong J

Subjects: Artificial Intelligence* ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/diagnostic imaging

  • Source: Neuro-oncology [Neuro Oncol] 2024 Jun 03; Vol. 26 (6), pp. 1124-1135.Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma.

  • Authors : Mohan A; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States.

Subjects: Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/Isocitrate Dehydrogenase*/genetics ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/drug therapy ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/genetics

  • Source: The oncologist [Oncologist] 2024 Aug 05; Vol. 29 (8), pp. 725-730.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.

  • Authors : Galbraith K; Department of Pathology, NYU Langone Health and NYU Grossman School of Medicine, New York, New York, USA.; Garcia M

Subjects: Astrocytoma*/Astrocytoma*/Astrocytoma*/genetics ; Astrocytoma*/Astrocytoma*/Astrocytoma*/pathology ; Astrocytoma*/Astrocytoma*/Astrocytoma*/mortality

  • Source: Neuro-oncology [Neuro Oncol] 2024 Jun 03; Vol. 26 (6), pp. 1042-1051.Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  667 results for ""Isocitrate Dehydrogenase""